Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP756396.RAnIrdZ45UNguliE8_leAIAmXGVeA8juhZ17Io3IWPCEA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP756396.RAnIrdZ45UNguliE8_leAIAmXGVeA8juhZ17Io3IWPCEA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP756396.RAnIrdZ45UNguliE8_leAIAmXGVeA8juhZ17Io3IWPCEA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP756396.RAnIrdZ45UNguliE8_leAIAmXGVeA8juhZ17Io3IWPCEA130_provenance.
- NP756396.RAnIrdZ45UNguliE8_leAIAmXGVeA8juhZ17Io3IWPCEA130_assertion description "[These results suggest that l-ase anticancer activity and glutamine uptake inhibition are promising new therapeutic strategies for AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP756396.RAnIrdZ45UNguliE8_leAIAmXGVeA8juhZ17Io3IWPCEA130_provenance.
- NP756396.RAnIrdZ45UNguliE8_leAIAmXGVeA8juhZ17Io3IWPCEA130_assertion evidence source_evidence_literature NP756396.RAnIrdZ45UNguliE8_leAIAmXGVeA8juhZ17Io3IWPCEA130_provenance.
- NP756396.RAnIrdZ45UNguliE8_leAIAmXGVeA8juhZ17Io3IWPCEA130_assertion SIO_000772 24014241 NP756396.RAnIrdZ45UNguliE8_leAIAmXGVeA8juhZ17Io3IWPCEA130_provenance.
- NP756396.RAnIrdZ45UNguliE8_leAIAmXGVeA8juhZ17Io3IWPCEA130_assertion wasDerivedFrom befree-20140225 NP756396.RAnIrdZ45UNguliE8_leAIAmXGVeA8juhZ17Io3IWPCEA130_provenance.
- NP756396.RAnIrdZ45UNguliE8_leAIAmXGVeA8juhZ17Io3IWPCEA130_assertion wasGeneratedBy ECO_0000203 NP756396.RAnIrdZ45UNguliE8_leAIAmXGVeA8juhZ17Io3IWPCEA130_provenance.
- befree-20140225 importedOn "2014-02-25" NP756396.RAnIrdZ45UNguliE8_leAIAmXGVeA8juhZ17Io3IWPCEA130_provenance.